Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Rae

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Pharmacogenetics and Genomics|June 7, 2021
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activityDaniel L Hertz, Julie A Douglas, Kelley M Kidwell, et al.
Oral Diseases|December 4, 2020
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancerCatherine Van Poznak, Evan L Reynolds, Cherry L Estilo, et al.
Breast Cancer Research and Treatment|December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerJason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Journal of Clinical Pharmacology|January 19, 2010
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patientsSilvana Borges, Zeruesenay Desta, Yan Jin, et al.
Cancer|February 7, 2007
Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell linesEdith J Mensah-Osman, Dafydd G Thomas, Michelle M Tabb, et al.
Investigational New Drugs|November 6, 2018
Pazopanib with low fat meal (PALM) in advanced renal cell carcinomaMelissa A Reimers, Maryann M Shango, Stephanie Daignault-Newton, et al.
Oncotarget|February 2, 2017
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancerMartina S J McDermott, Alexander A Chumanevich, Chang-Uk Lim, et al.
Pharmacogenomics|July 24, 2020
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathyYongzhen Chen, Fang Fang, Kelley M Kidwell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2022
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptomsDaniel L Hertz, Julie A Douglas, Robert M Miller, et al.
Breast Cancer Research and Treatment|January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN Lynn Henry, James M Rae, Lang Li, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Pharmacogenetics and Genomics|June 7, 2021
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activityDaniel L Hertz, Julie A Douglas, Kelley M Kidwell, et al.
Oral Diseases|December 4, 2020
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancerCatherine Van Poznak, Evan L Reynolds, Cherry L Estilo, et al.
Breast Cancer Research and Treatment|December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerJason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Journal of Clinical Pharmacology|January 19, 2010
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patientsSilvana Borges, Zeruesenay Desta, Yan Jin, et al.
Cancer|February 7, 2007
Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell linesEdith J Mensah-Osman, Dafydd G Thomas, Michelle M Tabb, et al.
Investigational New Drugs|November 6, 2018
Pazopanib with low fat meal (PALM) in advanced renal cell carcinomaMelissa A Reimers, Maryann M Shango, Stephanie Daignault-Newton, et al.
Oncotarget|February 2, 2017
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancerMartina S J McDermott, Alexander A Chumanevich, Chang-Uk Lim, et al.
Pharmacogenomics|July 24, 2020
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathyYongzhen Chen, Fang Fang, Kelley M Kidwell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2022
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptomsDaniel L Hertz, Julie A Douglas, Robert M Miller, et al.
Breast Cancer Research and Treatment|January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN Lynn Henry, James M Rae, Lang Li, et al.
Pageof 13